Life Sciences

Ian Koenig Featured in BioTuesdays Publication

|
Last month our SVP of Life Sciences, Ian Koenig, was featured in BioTuesdays. Ian sat down with th...

Last month our SVP of Life Sciences, Ian Koenig, was featured in BioTuesdays. Ian sat down with the online publication to discuss our Life Sciences practice and how we’re using our Connected Content approach to help revolutionize recruiting for clinical trials.

Alongside other important questions, Ian spoke about recruitment and enrollment issues that plague clinical trials, how Investis Digital is digitizing the recruitment process to ease these pain points, success stories we’ve seen, and more.

Ian noted, “We apply our Connected Content framework to develop a simple digital solution to achieve successful patient enrollment under tight timelines. Our success with targeted clinical trial recruitment is accomplished by leveraging unique data sets to build and model customized audiences, including patients, caregivers and physicians, for a specific clinical trial and region anywhere in the world. We combine online and offline strategies to engage with these identified audiences at a time when they’d be most receptive to take action. We also drive engaged audiences to screen for eligibility online and seamlessly direct highly qualified leads to local clinical sites. To maximize results, we collaborate with our partners consisting of PR agencies and contract research organizations (CROs). Together, we design integrated programs that identify and target audiences with content to engage and convert them with an elegant online/offline user experience.”

The full article, “Seven questions for Ian Koenig of Investis Digital about expediting patient recruitment for clinical trials,” is available to read on BioTuesday’s website. To learn more about our patient recruitment work, visit our website page or download our whitepaper for a closer look at the work we’ve done.

Contact Investis Digital

If you have any questions about our Life Sciences practice, please contact Ian Koenig at [email protected].